Adjunctive treatment with quetiapine for major depressive disorder: Are the benefits of treatment worth the risks?

Tamara Pringsheim; David Gardner; Scott B. Patten

doi:10.1136/bmj.h569

Adjunctive treatment with quetiapine for major depressive disorder: Are the benefits of treatment worth the risks?

Tamara Pringsheim, David Gardner, Scott B. Patten

Pharmacology, Toxicology and Pharmaceutics

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

Original language	English
Article number	h569
Journal	The BMJ
Volume	350
DOIs	https://doi.org/10.1136/bmj.h569
Publication status	Published - Mar 4 2015

ASJC Scopus Subject Areas

General Medicine

Access to Document

10.1136/bmj.h569

Cite this

@article{ebf98d86f1334b9698d6f40028bf0604,

title = "Adjunctive treatment with quetiapine for major depressive disorder: Are the benefits of treatment worth the risks?",

author = "Tamara Pringsheim and David Gardner and Patten, {Scott B.}",

year = "2015",

month = mar,

day = "4",

doi = "10.1136/bmj.h569",

language = "English",

volume = "350",

journal = "The BMJ",

issn = "0959-8146",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Adjunctive treatment with quetiapine for major depressive disorder

T2 - Are the benefits of treatment worth the risks?

AU - Pringsheim, Tamara

AU - Gardner, David

AU - Patten, Scott B.

PY - 2015/3/4

Y1 - 2015/3/4

UR - http://www.scopus.com/inward/record.url?scp=84925763766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925763766&partnerID=8YFLogxK

U2 - 10.1136/bmj.h569

DO - 10.1136/bmj.h569

M3 - Article

C2 - 25739588

AN - SCOPUS:84925763766

SN - 0959-8146

VL - 350

JO - The BMJ

JF - The BMJ

M1 - h569

ER -

Adjunctive treatment with quetiapine for major depressive disorder: Are the benefits of treatment worth the risks?

ASJC Scopus Subject Areas

Access to Document

Other files and links

Cite this